Whereas some effects of chemokine receptor inhibitors have been found in tumor settings, HIV infection and animal studies using models of autoimmunity, no promising clinical data on the efficacy of chemokine receptor inhibitors in RA have been reported41, 42 but no studies have been described so far targeting CXCR5. The gene discussed is CXCR5; the disease is HIV infectious disease.